Abstract:BACKGROUND CONTEXT: Elucidating the mechanism of neuropathic pain (NeP) is crucial as it can result in motor dysfunction and negatively impact quality of life in patients with spinal cord injury (SCI). Although it has been reported that cyclooxygenase 2 (COX2) is involved in NeP in rat models of peripheral nerve injury and that COX2 inhibitors can alleviate NeP, these mechanisms after SCI have not been fully investigated.PURPOSE: The purpose is to investigate whether the thoracic SCI affects the expression of mRNAs for COX1 and COX2 in the lumbar spinal cord, and the effect of COX2 inhibitor on its behavior.STUDY DESIGN: Male Sprague-Dawley (SD) rats underwent thoracic (T10) spinal cord contusion injury using an Infinite Horizon (IH) impactor device. SCI rats received COX2 inhibitors (50 μg/day) on days 5 and 6 after SCI.METHODS: Male SD rats underwent T10 laminectomy under mixed anesthesia, and IH impactors were applied to the same site to create a rat SCI model. Rats that underwent only laminectomy were designated as sham. Lumbar spinal cord at the L4-5 level was harvested at 3, 5, 7, 14, and 28 days after SCI, and COX2 and COX1 were quantified by reverse-transcription PCR (RT-PCR). COX2 expression, expression site, and expression time were determined by immunohistochemistry (IHC) and in situ hybridization histochemistry (ISHH) at the same time points. The expression site and time of COX2 expression were also examined at the same time point by ISHH. On 5th and 6th day after SCI, saline and COX2 inhibitor (50 μg/day) were administered into the subarachnoid space as a single dose, and the two groups were compared in terms of mechanical withdrawal latency using the dynamic plantar esthesiometer, which is an automated von Frey-type system.RESULTS: COX2 was significantly increased at 5 and 7 days after SCI, but no significant difference in COX1 was observed after SCI by RT-PCR. ISHH targeting COX2 showed clear expression of COX2 in spinal cord vascular endothelial cells at 5 and 7 days after SCI. COX2 expression was almost abolished at day 14 and 28. Behavioral experiments showed that pain was significantly improved from day 2 after COX2 inhibitor administration compared to the saline group, with improvement up to day 14 after SCI, but no significant difference was observed after day 21.CONCLUSIONS: The present findings suggest that thoracic SCI increased COX2 in vascular endothelial cells in the lumbar spinal cord and that the administration of COX2 inhibitor significantly alleviated mechanical hypersensitivity of the hind-paw following the thoracic SCI. Therefore, endothelial cell derived COX2 in the lumbar spinal cord may be involved in the induction of neuropathic pain in the SCI model rats.CLINICAL SIGNIFICANCE: The findings in the present study regarding the induction of endothelial COX2 and the effect of its inhibitor on the mechanical hypersensitivity suggest that endothelial cell-derived COX2 is one of the focuses for the treatment for neuropathic pain in the acute phase of SCI.

COX‐2 is Required for the Modulation of Spinal Nociceptive Information Related to Ephrinb/ephb Signalling

Pi3k Contributed To Modulation Of Spinal Nociceptive Information Related To Ephrinbs/Ephbs

Spinal NF-kB upregulation contributes to hyperalgesia in a rat model of advanced osteoarthritis

PKA is Required for the Modulation of Spinal Nociceptive Information Related to Ephrinb–ephb Signaling in Mice

COX2 expression plays a role in spinal cord injury-induced neuropathic pain

EphrinB-EphB Signaling Induces Hyperalgesia through ERK5/CREB Pathway in Rats.

Effects of Cyclooxygenase 2 Inhibitor on Growth-Associated Protein 43 and Nerve Growth Factor Expression in Dorsal Root Ganglion During Neuropathic Pain Development

Role of cyclooxygenases in up-regulation of P2X3 receptor expression in dorsal root ganglion in rats with neuropathic pain

Analgesic Effects of the Cox-2 Inhibitor Parecoxib on Surgical Pain Through Suppression of Spinal Erk Signaling

Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

Role of CREB-binding protein in cyclooxygenase 2 expression in spinal cord in a rat model of neuropathic pain

Cx3cl1/Cx3cr1 Regulates Nerve Injury-Induced Pain Hypersensitivity Through The Erk5 Signaling Pathway

Spinal ephrin<scp>B</scp>/<scp>EphB</scp> signalling contributed to remifentanil‐induced hyperalgesia via <scp>NMDA</scp> receptor

Upregulation and Redistribution of Ephrinb and Ephb Receptor in Dorsal Root Ganglion and Spinal Dorsal Horn Neurons after Peripheral Nerve Injury and Dorsal Rhizotomy

Synergistic Anti-Hyperalgesia of Electroacupuncture and Low Dose of Celecoxib in Monoarthritic Rats: Involvement of the Cyclooxygenase Activity in the Spinal Cord

Effects of Electroacupuncture on Expression of COX-2 in the Dorsal Horn of Spinal Cord of Arthritic Rats

Activation of spinal ephrin-B3/EphBs signaling induces hyperalgesia through a PLP-mediated mechanism

ERK MAP Kinase Activation in Spinal Cord Regulates Phosphorylation of Cdk5 at Serine 159 and Contributes to Peripheral Inflammation Induced Pain/hypersensitivity.

C-X-C Motif Chemokine Ligand 1 and Its Receptor C-X-C Motif Chemokine Receptor 2 in Trigeminal Ganglion Contribute to Nerve Injury-Induced Orofacial Mechanical Allodynia.

CXCR3 signalling partially contributes to the pathogenesis of neuropathic pain in male rodents

Reduced potassium-chloride co-transporter expression in spinal cord dorsal horn neurons contributes to inflammatory pain hypersensitivity in rats